{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:21:57Z","timestamp":1790403717422,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.diabres.2017.03.003","type":"journal-article","created":{"date-parts":[[2017,3,12]],"date-time":"2017-03-12T11:01:23Z","timestamp":1489316483000},"page":"303-316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":265,"special_numbering":"C","title":["Diabetes and Ramadan: Practical guidelines"],"prefix":"10.1016","volume":"126","author":[{"given":"Mohamed","family":"Hassanein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monira","family":"Al-Arouj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Mohamad Wan","family":"Bebakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Jabbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrazzaq","family":"Al-Madani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasim","family":"Hanif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Lessan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Basit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Tayeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MAK","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalifa","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz","family":"Al Twaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Akif","family":"Buyukbese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel A.","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Ben-Nakhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2017.03.003_b0005","unstructured":"International diabetes federation. IDF Diabetes Atlas (Seventh Edition); 2015. <http:\/\/www.diabetesatlas.org\/resources\/2015-atlas.html>. [accessed 09 February 2016]."},{"key":"10.1016\/j.diabres.2017.03.003_b0010","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.2337\/diacare.27.10.2306","article-title":"A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422\/2001 (EPIDIAR) study","volume":"27","author":"Salti","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.03.003_b0015","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/dme.12685","article-title":"Multi-country retrospective observational study of the management and outcomes of patients with Type 2 diabetes during Ramadan in 2010 (CREED)","volume":"32","author":"Babineaux","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2017.03.003_b0020","doi-asserted-by":"publisher","first-page":"e60917","DOI":"10.1371\/journal.pone.0060917","article-title":"Relative metabolic stability, but disrupted circadian cortisol secretion during the fasting month of Ramadan","volume":"8","author":"Bahijri","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.diabres.2017.03.003_b0025","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.appet.2010.01.011","article-title":"Circadian pattern of sleep, energy expenditure, and body temperature of young healthy men during the intermittent fasting of Ramadan","volume":"54","author":"BaHammam","year":"2010","journal-title":"Appetite"},{"key":"10.1016\/j.diabres.2017.03.003_b0030","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1046\/j.1365-2869.2001.00269.x","article-title":"Sleep during Ramadan intermittent fasting","volume":"10","author":"Roky","year":"2001","journal-title":"J Sleep Res"},{"key":"10.1016\/j.diabres.2017.03.003_b0035","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1055\/s-2008-1065321","article-title":"How Ramadan fasting affects caloric consumption, body weight, and circadian evolution of cortisol serum levels in young, healthy male volunteers","volume":"40","author":"Haouari","year":"2008","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.diabres.2017.03.003_b0040","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.2337\/dc10-0896","article-title":"Recommendations for management of diabetes during Ramadan: update 2010","volume":"33","author":"Al-Arouj","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.03.003_b0045","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1210\/jc.2014-3911","article-title":"Subchronic sleep restriction causes tissue-specific insulin resistance","volume":"100","author":"Rao","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2017.03.003_b0050","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/S0140-6736(99)01376-8","article-title":"Impact of sleep debt on metabolic and endocrine function","volume":"354","author":"Spiegel","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2017.03.003_b0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2015.06.003","article-title":"Sleep duration and insulin resistance in individuals without diabetes mellitus: a systematic review and meta-analysis","volume":"109","author":"Upala","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2017.03.003_b0060","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1006\/appe.1998.0164","article-title":"Appetite changes under free-living conditions during Ramadan fasting","volume":"31","author":"Finch","year":"1998","journal-title":"Appetite"},{"key":"10.1016\/j.diabres.2017.03.003_b0065","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1258\/jrsm.2010.090254","article-title":"Review of diabetes management and guidelines during Ramadan","volume":"103","author":"Karamat","year":"2010","journal-title":"J R Soc Med"},{"key":"10.1016\/j.diabres.2017.03.003_b0070","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.diabet.2014.11.004","article-title":"Glucose excursions and glycaemic control during Ramadan fasting in diabetic patients: Insights from continuous glucose monitoring (CGM)","volume":"41","author":"Lessan","year":"2015","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabres.2017.03.003_b0075","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s10943-013-9687-0","article-title":"Does Ramadan fasting alter body weight and blood lipids and fasting blood glucose in a healthy population? A meta-analysis","volume":"53","author":"Kul","year":"2014","journal-title":"J Relig Health"},{"key":"10.1016\/j.diabres.2017.03.003_b0080","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/2251-6581-13-37","article-title":"Implementation of Ramadan-specific diabetes management recommendations: a multi-centered prospective study from Pakistan","volume":"13","author":"Ahmedani","year":"2014","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.diabres.2017.03.003_b0085","first-page":"514","article-title":"Comparison of incidences, hospital stay and precipitating factors of diabetic ketoacidosis in Ramadan and the following month in three major hospitals in United Arab Emirates. A prospective observational study","volume":"6","author":"Abdelgadir","year":"2015","journal-title":"J Diabetes Metab"},{"key":"10.1016\/j.diabres.2017.03.003_b0090","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.2337\/diacare.28.9.2305","article-title":"Recommendations for management of diabetes during Ramadan","volume":"28","author":"Al-Arouj","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.03.003_b0095","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4103\/1947-489X.211054","article-title":"Fasting during the month of Ramadan for people with diabetes: Medicine and Fiqh united at last","volume":"1","author":"Beshyah","year":"2009","journal-title":"Ibnosina J Med Biomed Sci"},{"key":"10.1016\/j.diabres.2017.03.003_b0100","doi-asserted-by":"publisher","first-page":"20","DOI":"10.15277\/bjd.2016.058","article-title":"Use of SGLT2 inhibitors during Ramadan: a survey of physicians\u2019 views and practical guidance","volume":"16","author":"Beshyah","year":"2016","journal-title":"Br J Diabetes"},{"key":"10.1016\/j.diabres.2017.03.003_b0105","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1464-5491.2010.02948.x","article-title":"Ramadan education and awareness in diabetes (READ) programme for muslims with Type 2 diabetes who fast during Ramadan","volume":"27","author":"Bravis","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2017.03.003_b0110","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1464-5491.2011.03563.x","article-title":"Ramadan prospective diabetes study: the role of drug dosage and timing alteration, active glucose monitoring and patient education","volume":"29","author":"Ahmedani","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2017.03.003_b0115","doi-asserted-by":"publisher","first-page":"794","DOI":"10.4103\/2230-8210.140242","article-title":"Management of Type 2 diabetes in Ramadan: Low-ratio premix insulin working group practical advice","volume":"18","author":"Hassanein","year":"2014","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.diabres.2017.03.003_b0120","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.2337\/dc16-S006","article-title":"3. Foundations of care and comprehensive medical evaluation","volume":"39","author":"American Diabetes Association","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.03.003_b0125","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/0973-3930.28276","article-title":"A double-blind, randomized, multicenter study evaluating the effects of pioglitazone in fasting Muslim subjects during Ramadan","volume":"26","author":"Vasan","year":"2006","journal-title":"Int J Diabetes Dev Ctries"},{"key":"10.1016\/j.diabres.2017.03.003_b0130","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00592-008-0062-7","article-title":"Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk Type 2 diabetic patients who insist on fasting in Ramadan","volume":"46","author":"Bakiner","year":"2009","journal-title":"Acta Diabetologica"},{"key":"10.1016\/j.diabres.2017.03.003_b0135","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1081\/ERC-200027375","article-title":"The effects of diet, sulfonylurea, and repaglinide therapy on clinical and metabolic parameters in Type 2 diabetic patients during Ramadan","volume":"30","author":"Sari","year":"2004","journal-title":"Endocr Res"},{"key":"10.1016\/j.diabres.2017.03.003_b0140","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.diabres.2006.05.012","article-title":"A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in Type 2 diabetes mellitus during Ramadan fasting","volume":"75","author":"Cesur","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2017.03.003_b0145","first-page":"28","article-title":"An open label comparative study of glimepiride versus repaglinide in Type 2 diabetes mellitus Muslim subjects during the month of Ramadan","volume":"61","author":"Anwar","year":"2006","journal-title":"Med J Malaysia"},{"key":"10.1016\/j.diabres.2017.03.003_b0150","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0168-8227(02)00104-3","article-title":"Repaglinide versus glibenclamide treatment of Type 2 diabetes during Ramadan fasting","volume":"58","author":"Mafauzy","year":"2002","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2017.03.003_b0155","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1185\/03007995.2011.578245","article-title":"Hypoglycaemia in sulphonylurea-treated subjects with Type 2 diabetes undergoing Ramadan fasting: a five-country observational study","volume":"27","author":"Aravind","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.diabres.2017.03.003_b0160","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/ijcp.12243","article-title":"The effect of vildagliptin relative to sulphonylureas in Muslim patients with Type 2 diabetes fasting during Ramadan: the VIRTUE study","volume":"67","author":"Al-Arouj","year":"2013","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.diabres.2017.03.003_b0165","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/j.1742-1241.2011.02797.x","article-title":"The incidence of hypoglycaemia in Muslim patients with Type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial","volume":"65","author":"Al Sifri","year":"2011","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.diabres.2017.03.003_b0170","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1136\/bmj.307.6899.292","article-title":"Muslims with non-insulin dependent diabetes fasting during Ramadan: treatment with glibenclamide","volume":"307","author":"Belkhadir","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2017.03.003_b0175","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1185\/03007995.2012.707119","article-title":"Hypoglycemia in patients with Type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study","volume":"28","author":"Aravind","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.diabres.2017.03.003_b0180","first-page":"319","article-title":"A double-blind, randomized trial, including frequent patient-physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with Type 2 diabetes fasting during Ramadan: the STEADFAST study","volume":"10","author":"Hassanein","year":"2014","journal-title":"Vasc Health Risk Manage"},{"key":"10.1016\/j.diabres.2017.03.003_b0185","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2337\/diacare.28.2.421","article-title":"The efficacy and safety of glimepiride in the management of Type 2 diabetes in Muslim patients during Ramadan","volume":"28","author":"GLIRA Study Group","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.03.003_b0190","unstructured":"Food and Drug Adminstration. FDA Drug Safety Communication [December 04, 2015]: FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections; 2015. <http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm475463.htm>. [accessed 24 February 2016]."},{"key":"10.1016\/j.diabres.2017.03.003_b0195","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1038\/nutd.2014.40","article-title":"Efficacy, safety and regulatory status of SGLT2 inhibitors: focus on canagliflozin","volume":"4","author":"Haas","year":"2014","journal-title":"Nutr Diabetes"},{"key":"10.1016\/j.diabres.2017.03.003_b0200","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/dom.12649","article-title":"Switching from sulphonylurea to a sodium-glucose cotransporter2 inhibitor in the fasting month of Ramadan is associated with a reduction in hypoglycaemia","volume":"18","author":"Wan Seman","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2017.03.003_b0205","unstructured":"Kamaruddin N, Wan Seman WJ, Kori N, et al., Assessment of dehydration parameters with dapagliflozin in patients with Type 2 diabetes mellitus during Ramadan fasting month (ePoster #757). In: Presented at the 51st annual meeting of the European association for the study of diabetes, Stockholm, Sweden; September 15\u201318, 2015."},{"key":"10.1016\/j.diabres.2017.03.003_b0210","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/2042018814529062","article-title":"Glycemic effects of vildagliptin in patients with Type 2 diabetes before, during and after the period of fasting in Ramadan","volume":"5","author":"Malha","year":"2014","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.diabres.2017.03.003_b0215","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1111\/j.1742-1241.2009.02171.x","article-title":"Vildagliptin therapy and hypoglycaemia in Muslim Type 2 diabetes patients during Ramadan","volume":"63","author":"Devendra","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.diabres.2017.03.003_b0220","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s13300-013-0038-7","article-title":"Experience with vildagliptin in Type 2 diabetic patients fasting during Ramadan in France: Insights from the VERDI study","volume":"4","author":"Halimi","year":"2013","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabres.2017.03.003_b0225","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1185\/03007995.2011.579951","article-title":"Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with Type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study","volume":"27","author":"Hassanein","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.diabres.2017.03.003_b0230","doi-asserted-by":"publisher","first-page":"358","DOI":"10.4239\/wjd.v4.i6.358","article-title":"Vildagliptin vs sulfonylurea in Indian Muslim diabetes patients fasting during Ramadan","volume":"4","author":"Shete","year":"2013","journal-title":"World J Diabetes"},{"key":"10.1016\/j.diabres.2017.03.003_b0235","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/dom.12249","article-title":"A randomized controlled trial comparing the GLP-1 receptor agonist liraglutide to a sulphonylurea as add on to metformin in patients with established Type 2 diabetes during Ramadan: the Treat 4 Ramadan Trial","volume":"16","author":"Brady","year":"2014","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.diabres.2017.03.003_b0240","unstructured":"Azar S, Echtay A, Wan Bebakar W, et al. Efficacy and safety of liraglutide versus sulphonylurea, both in combination with metformin, during Ramadan in subjects with Type 2 diabetes (LIRA-Ramadan): a randomised trial (OP #162). In: Presented at the 51st annual meeting of the European association for the study of diabetes, Stockholm, Sweden; September 15\u201318, 2015."},{"key":"10.1016\/j.diabres.2017.03.003_b0245","doi-asserted-by":"publisher","first-page":"590","DOI":"10.4172\/2155-6156.1000590","article-title":"Safety and efficacy of liraglutide as an add-on therapy to pre-existing anti-diabetic regimens during Ramadan, a prospective observational trial","volume":"6","author":"Khalifa","year":"2015","journal-title":"J Diabetes Metab"},{"key":"10.1016\/j.diabres.2017.03.003_b0250","first-page":"130","article-title":"A comparative analysis of exenatide and gliclazide during the month of Ramadan","volume":"27","author":"Bravis","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2017.03.003_b0255","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.2337\/dc14-0031","article-title":"Insulin analogs\u2013are they worth it? Yes!","volume":"37","author":"Grunberger","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.03.003_b0260","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/j.1464-5491.2009.02836.x","article-title":"Efficacy and safety of insulin glargine and glimepiride in subjects with Type 2 diabetes before, during and after the period of fasting in Ramadan","volume":"26","author":"Salti","year":"2009","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2017.03.003_b0265","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1046\/j.1464-5491.1999.00164.x","article-title":"Insulin lispro (Lys(B28), Pro(B29) in the treatment of diabetes during the fasting month of Ramadan. Ramadan Study Group","volume":"16","author":"Akram","year":"1999","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2017.03.003_b0270","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0168-8227(02)00202-4","article-title":"A comparison of insulin lispro Mix25 and human insulin 30\/70 in the treatment of Type 2 diabetes during Ramadan","volume":"59","author":"Mattoo","year":"2003","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2017.03.003_b0275","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/j.1742-1241.2010.02347.x","article-title":"Comparison of Humalog Mix 50 with human insulin Mix 30 in Type 2 diabetes patients during Ramadan","volume":"64","author":"Hui","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.diabres.2017.03.003_b0280","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1111\/ijcp.12695","article-title":"Effect of a new insulin treatment regimen on glycaemic control and quality of life of Muslim patients with Type 2 diabetes mellitus during Ramadan fast - an open label, controlled, multicentre, cluster randomised study","volume":"69","author":"Shehadeh","year":"2015","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.diabres.2017.03.003_b0285","first-page":"574","article-title":"A multicenter, prospective, non-interventional evaluation of efficacy and safety of using biphasic insulin aspart as monotherapy, or in combination with oral hypoglycemic agent, in the treatment of Type 2 diabetic patients before, during & after Ramadan","volume":"59","author":"Soewondo","year":"2009","journal-title":"J Indones Med Assoc"},{"key":"10.1016\/j.diabres.2017.03.003_b0290","article-title":"Should Type 1 diabetics fast in Ramadan","volume":"65","author":"Mohsin","year":"2015","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.diabres.2017.03.003_b0295","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.2337\/dc15-1108","article-title":"Blood glucose fluctuation during Ramadan fasting in adolescents with Type 1 diabetes: findings of continuous glucose monitoring","volume":"38","author":"Kaplan","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.03.003_b0300","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.2337\/diacare.27.5.1209","article-title":"Fasting and insulin glargine in individuals with Type 1 diabetes","volume":"27","author":"Mucha","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.03.003_b0305","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/BF03347569","article-title":"Insulin therapy during Ramadan fast for Type 1 diabetes patients","volume":"28","author":"Kassem","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.diabres.2017.03.003_b0310","first-page":"482","article-title":"Treatment of Type 1 diabetes with insulin lispro during Ramadan","volume":"27","author":"Kadiri","year":"2001","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabres.2017.03.003_b0315","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1089\/dia.2009.0130","article-title":"Insulin pump therapy in Moslem patients with Type 1 diabetes during Ramadan fasting: an observational report","volume":"12","author":"Benbarka","year":"2010","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2017.03.003_b0320","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1089\/dia.2012.0061","article-title":"Ramadan fasting in diabetes patients on insulin pump therapy augmented by continuous glucose monitoring: an observational real-life study","volume":"14","author":"Khalil","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2017.03.003_b0325","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ijdm.2010.05.009","article-title":"Effects of Ramadan fasting on children with Type 1 diabetes","volume":"2","author":"AlAlwan","year":"2010","journal-title":"Int J Diabetes Mellit"},{"key":"10.1016\/j.diabres.2017.03.003_b0330","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1399-5448.2009.00544.x","article-title":"Adolescents on basal-bolus insulin can fast during Ramadan","volume":"11","author":"Al-Khawari","year":"2010","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.diabres.2017.03.003_b0335","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4103\/0256-4947.51709","article-title":"Insulin pump therapy during Ramadan fasting in Type 1 diabetic adolescents","volume":"28","author":"Bin-Abbas","year":"2008","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.diabres.2017.03.003_b0340","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/2230-8210.126530","article-title":"Fasting during Ramadan in adolescents with diabetes","volume":"18","author":"Zabeen","year":"2014","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.diabres.2017.03.003_b0345","doi-asserted-by":"publisher","first-page":"516","DOI":"10.4103\/2230-8210.97998","article-title":"Fasting guidelines for diabetic children and adolescents","volume":"16","author":"Azad","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.diabres.2017.03.003_b0350","doi-asserted-by":"publisher","first-page":"536","DOI":"10.4103\/1755-6783.133710","article-title":"Fasting in pregnancy: a survey of beliefs and manners of Muslim women about Ramadan fasting","volume":"6","author":"Firouzbakht","year":"2013","journal-title":"Ann Trop Med Public Health"},{"key":"10.1016\/j.diabres.2017.03.003_b0355","article-title":"Each one is a doctor for herself: Ramadan fasting among pregnant Muslim women in the United States","volume":"15","author":"Robinson","year":"2005","journal-title":"Ethn Dis"},{"key":"10.1016\/j.diabres.2017.03.003_b0360","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1257\/app.3.4.56","article-title":"Health capital and the prenatal environment: the effect of Ramadan observance during pregnancy","volume":"3","author":"Almond","year":"2011","journal-title":"Am Econ J Appl Econ"},{"key":"10.1016\/j.diabres.2017.03.003_b0365","first-page":"91","article-title":"Interrelation of Ramadan fasting and birth weight","volume":"14","author":"Arab","year":"2001","journal-title":"Med J Islamic Academy Sci"},{"key":"10.1016\/j.diabres.2017.03.003_b0370","first-page":"583","article-title":"A survey of fasting during pregnancy","volume":"45","author":"Joosoph","year":"2004","journal-title":"Singapore Med J"},{"key":"10.1016\/j.diabres.2017.03.003_b0375","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/j.1447-0756.2008.00814.x","article-title":"Effect of fasting during Ramadan on fetal development and maternal health","volume":"34","author":"Dikensoy","year":"2008","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.diabres.2017.03.003_b0380","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00404-008-0680-x","article-title":"The effect of Ramadan fasting on maternal serum lipids, cortisol levels and fetal development","volume":"279","author":"Dikensoy","year":"2009","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.diabres.2017.03.003_b0385","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/sj.jp.7211189","article-title":"Maternal Ramadan fasting and neonatal health","volume":"24","author":"Kavehmanesh","year":"2004","journal-title":"J Perinatol"},{"key":"10.1016\/j.diabres.2017.03.003_b0390","first-page":"181","article-title":"The effect of Ramadan fasting on outcome of pregnancy","volume":"20","author":"Ziaee","year":"2010","journal-title":"Iran J Pediatr"},{"key":"10.1016\/j.diabres.2017.03.003_b0395","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.placenta.2010.04.010","article-title":"Changes in placental size during Ramadan","volume":"31","author":"Alwasel","year":"2010","journal-title":"Placenta"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822717303388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822717303388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T16:56:01Z","timestamp":1568912161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822717303388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":79,"alternative-id":["S0168822717303388"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2017.03.003","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes and Ramadan: Practical guidelines","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2017.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}